Investigations performed at Pediatric Orthopaedics; Department of Trauma, Orthopaedic and Plastic Surgery, University Medical Center Göttingen, Göttingen, Germany.
Department of Pediatric Orthopaedics; Asklepios, Sankt Augustin, Germany.
Neurosurgery. 2020 Oct 15;87(5):910-917. doi: 10.1093/neuros/nyaa053.
Almost all children with spinal muscular atrophy (SMA) develop a scoliosis during childhood and adolescence. In the last decades, growth-friendly spinal implants have been established as an interim solution for these patients until definite spinal fusion can be performed. The effect of those implants on the final outcome has yet to be described.
To assess the effect of prior growth-friendly spinal surgical treatment on the outcome after spinal fusion in SMA children in comparison to untreated SMA patients through the prospective study.
A total of 28 SMA patients with (n = 14) and without (n = 14) prior surgical treatment with growth-friendly implants were included. Average surgical treatment prior to definite spinal fusion was 4.9 yr. Scoliotic curve angle, pelvic obliquity, spinal length, kyphosis, and lordosis were evaluated for children with prior treatment and before and after dorsal spondylodesis for all children.
The curve angle before definite spinal fusion averaged at 104° for SMA patients without prior treatment and 71° for patients with prior treatment. Spondylodesis reduced the scoliotic curve to 50° and 33°, respectively, which equals a correction of 52% vs 54%. Pelvic obliquity could be improved by spinal fusion in all patients with better results in the pretreated group. Results for spinal length, kyphosis, and lordosis were similar in both groups.
These data show the positive effect of prior growth-friendly surgical treatment on radiographic results of spinal fusion in children with SMA. Both scoliotic curve angles and pelvic obliquity showed significantly better values when patients had growth-friendly implants before definite spinal fusion.
几乎所有脊髓性肌萎缩症(SMA)患儿在儿童期和青春期都会出现脊柱侧凸。在过去的几十年中,为这些患者建立了可促进生长的脊柱植入物作为临时解决方案,直到可以进行确定性脊柱融合。这些植入物对最终结果的影响尚未被描述。
通过前瞻性研究,评估在 SMA 患儿中,与未经治疗的 SMA 患者相比,先前接受可促进生长的脊柱外科治疗对脊柱融合后结果的影响。
共纳入 28 例 SMA 患儿,其中 14 例(治疗组)和 14 例(未治疗组)患儿在确定性脊柱融合之前接受过可促进生长的植入物的外科治疗。在进行确定性脊柱融合之前,平均有 4.9 年的矫形手术史。对接受过治疗的患儿评估治疗前和所有患儿后路脊柱融合前后的脊柱侧凸角度、骨盆倾斜度、脊柱长度、后凸和前凸。
未经治疗的 SMA 患儿在进行确定性脊柱融合前的平均脊柱侧凸角度为 104°,而接受过治疗的患儿为 71°。脊柱融合将脊柱侧凸角度分别降低至 50°和 33°,矫正率分别为 52%和 54%。所有患者的骨盆倾斜度均可通过脊柱融合得到改善,且在预处理组中结果更好。两组的脊柱长度、后凸和前凸结果相似。
这些数据表明,在 SMA 患儿中,先前接受可促进生长的外科治疗对脊柱融合的影像学结果有积极影响。当患者在进行确定性脊柱融合前有可促进生长的植入物时,脊柱侧凸角度和骨盆倾斜度的改善更加显著。